← European Medicine Shortage Tracker · all medicines

Hydroklortiazid, irbesartan shortage — availability across Europe

Name: European Medicine Shortage Tracker dataset
Creator: MobiDoctor
License: https://creativecommons.org/licenses/by/4.0/

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Hydroklortiazid, irbesartan currently has availability issues reported in 2 European registers: Italy, Sweden.

Shortage ATC — · also listed as: IDROCLOROTIAZIDE + IRBESARTAN · hydroklortiazid, irbesartan · data refreshed 8 September 2026

Key facts

As of 8 September 2026, Hydroklortiazid, irbesartan has active availability issues in 2 of 9 tracked European registers.
Registers reporting issues: Italy, Sweden.
Latest expected-resolution date on file: 2026-12-31.
Longest-running open report: since 2022-09-26 (48 months, Italy).
Data source: 2 official medicines-agency registers, refreshed daily.

As of 8 September 2026, 2 of the 9 tracked registers list current availability issues for Hydroklortiazid, irbesartan, covering 9 affected product presentations. The longest-running open report was filed in Italy on 2022-09-26 and has now been open for about 48 months. Where agencies state a cause, manufacturing problems lead with 7 of the 7 stated-cause reports. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-12-31. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇮🇹 Italy	Shortage IRBESARTAN E IDROCLOROTIAZIDE AUROBINDO + 6 more products IRBESARTAN E IDROCLOROTIAZIDE MYLAN IRBESARTAN E IDROCLOROTIAZIDE MYLAN IRBESARTAN E IDROCLOROTIAZIDE MYLAN IRBESARTAN HYDROCLOROTHIAZIDE ZENTIVA IRBESARTAN HYDROCLOROTHIAZIDE ZENTIVA IRBESARTAN HYDROCLOROTHIAZIDE ZENTIVA	2022-09-26	—	Problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available.	register ↗
🇸🇪 Sweden	Shortage Irbesartan/Hydroklortiazid Actavis 300 mg/12,5 mg Filmdragerad tablett + 1 more products Irbesartan/Hydroklortiazid Actavis 300 mg/25 mg Filmdragerad tablett	2026-06-01	2026-12-31	— Alternatives: Alternative(s) available — see the national register.	register ↗

New register reports per month

Full report history (9 register entries)

Every individual register entry for Hydroklortiazid, irbesartan in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇮🇹 IT	IRBESARTAN E IDROCLOROTIAZIDE MYLAN	Shortage	2026-10-01	—	Problemi produttivi
🇮🇹 IT	IRBESARTAN E IDROCLOROTIAZIDE AUROBINDO	Shortage	2026-09-02	—	Problemi produttivi
🇮🇹 IT	IRBESARTAN E IDROCLOROTIAZIDE MYLAN	Shortage	2026-06-01	—	Problemi produttivi
🇸🇪 SE	Irbesartan/Hydroklortiazid Actavis 300 mg/12,5 mg Filmdragerad tablett	Shortage	2026-06-01	2026-12-31
🇸🇪 SE	Irbesartan/Hydroklortiazid Actavis 300 mg/25 mg Filmdragerad tablett	Shortage	2026-06-01	2026-12-31
🇮🇹 IT	IRBESARTAN E IDROCLOROTIAZIDE MYLAN	Shortage	2026-05-15	—	Problemi produttivi
🇮🇹 IT	IRBESARTAN HYDROCLOROTHIAZIDE ZENTIVA	Shortage	2023-12-31	—	Problemi produttivi
🇮🇹 IT	IRBESARTAN HYDROCLOROTHIAZIDE ZENTIVA	Shortage	2023-09-30	—	Problemi produttivi
🇮🇹 IT	IRBESARTAN HYDROCLOROTHIAZIDE ZENTIVA	Shortage	2022-09-26	—	Problemi produttivi

Frequently asked

Is Hydroklortiazid, irbesartan currently in shortage in Europe?

Yes. As of 8 September 2026, availability issues are reported in: Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Hydroklortiazid, irbesartan shortage expected to end?

Agency prognoses on file range from 2026-12-31 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Hydroklortiazid, irbesartan?

9 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Hydroklortiazid, irbesartan availability data come from?

Directly from the official medicines-agency registers that list Hydroklortiazid, irbesartan: AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Hydroklortiazid, irbesartan — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/hydroklortiazid-irbesartan/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Hydroklortiazid, irbesartan availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/hydroklortiazid-irbesartan/">Hydroklortiazid, irbesartan shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Hydroklortiazid, irbesartan: availability status across 2 European registers — European Medicine Shortage Tracker (MobiDoctor), 8 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.